Synthetic Biology Market North America – Forecast (2017-2026) _ by Product (Enabling Products and Core Products), by Technology (Genome Engineering, DND Sequencing and Others), by Application and by Geography

Synthetic Biology Market North America – Forecast (2017-2026) _ by Product (Enabling Products and Core Products), by Technology (Genome Engineering, DND Sequencing and Others), by Application and by Geography

Market Scenario

Synthetic Biology Market North America is expected to reach US$ XXBn by 2026 from US$ XXBn in 2017 at a CAGR of XX% (Detailed analysis of the market CAGR is provided in the report). Synthetic biology is a form of engineering application in biology that involves the complex synthesis of biologically inspired systems that display functions otherwise non-existent in nature. Engineering perspective can be applied at various levels of biological structure hierarchy from molecules and whole cells to tissues and organisms. Synthetic biology enables designing of biological systems in a systematic way. It further combines knowledge of genomics with chemical synthesis of DNA to make researchers manufacture DNA sequences that are cataloged and then assemble them into genomes. North America Synthetic Biology Market Synthetic Biology market for North America has been segmented on the basis of product, technology, application, and geography. Based on products, the market has been divided into enabling and core products. Enabling products have held a larger market share with more laboratories receiving funds to develop organisms that are genetically evolved and rationally engineered. This combines process development with art screening and then using analytical methodologies for making advancement in a concept and then develop it for commercialization. DNA synthesis and sequencing have resulted in construction as well as the characterization of metabolically developed organisms through engineering. On the basis of technology, the market for synthetic biology has been segmented into genome engineering, DNA sequencing, Biological components, and integrated systems and Bioinformatics among others. Genome engineering and DNA sequencing have been two major segments with advanced engineering developments for the synthetic formation of new cells helping in the overall application of these segments. Application wise, it is chemicals, healthcare, and agriculture among others that have formed the main segments. Healthcare and agriculture have formed two dominant segments with healthcare holding the largest one. The rise in demand for genetically advanced microorganisms that may help cure terminally ill diseases has been a major reason that has led to high applications of synthetic biology in the healthcare sector. In addition to this, there has been a rise in concern regarding the cultivation of crops. Rapid growth in population and pollution has resulted in a growing need for genetically advanced crops that may satisfy the growing hungry population. The focus is also being given to modifying crops so as to protect them from drastic environmental changes thereby saving the world form upcoming plague that may result due to the scarcity of food. North America has been a leading market for synthetic biology globally and has been segmented on the basis of countries into US and Canada. US is holding the largest market share with Canada monitoring one of the highest CAGR. Rise in researchers across laboratories to work for the development of synthetically advanced organisms that may help human to survive in the long run along with growing investments by the government to fund these researchers have been a few key factors that have helped in the growth of synthetic biology market in North America. Key Highlights: • North America Synthetic Biology market size analysis and forecast • Comprehensive study and analysis of market drivers, restraints, and opportunities influencing the growth of the North America Synthetic Biology market • Synthetic Biology market segmentation on the basis of product, technology, application, and geography. • Synthetic Biology market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of a study • Synthetic Biology market analysis and forecast for major countries has been provided. • Profiling of key industry players, their strategic perspective, market positioning and analysis of core competencies • Competitive landscape of the key players operating in the Synthetic Biology market including competitive developments, investments, and strategic expansion Research Methodology The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the market value for North America Synthetic Biology market Some of the key players of the North America Synthetic Biology market include: • Thermo Fisher Scientific Inc. • Integrated DNA Technologies, Inc. • Synthetic Genomics Inc. • Genscript Corporation • Amyris • Intrexon • Dupont • Agilent Technologies • Twist Bioscience • Origene Technologies, Inc. Key Target Audience: • Research and consulting firms • Healthcare industries • Synthetic Biology Market Investors • Chemical & Biofuel industries • Pharmaceutical & drug manufacturers • Hospitals and Clinics • Contract research organizations (CROs) and Contract manufacturing organizations (CMOs) • Biotech, Food & agriculture , Pharmaceutical & drug manufacturers • Synthetic Biology Marketing Players

Scope of the Synthetic Biology Market Report:

The research report segments North America Synthetic Biology market based on product, technology, application and geography.

Synthetic Biology Market, By Product:

• Enabling • Core

Synthetic Biology Market, By Technology:

• Genome Engineering • DNA Sequencing • Bioinformatics • Biological components and integrated systems • Others

Synthetic Biology Market, By Application:

• Chemicals • Healthcare • Agriculture • Others

Synthetic Biology Market, By Geography:

• US • Canada Geographic Analysis • Breakdown of US Synthetic Biology market • Breakdown of Canada Synthetic Biology market Available Customizations Maximize Market Research offers customizations of reports according to the specific requirement of our clients

Table of Contents

North America Synthetic Biology Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. North America Synthetic Biology Market Size, by Market Value (US$ Bn ) and Market, by Country 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 5. North America Synthetic Biology Market Analysis and Forecast 5.1. North America Synthetic Biology Market Analysis and Forecast 5.2. North America Synthetic Biology Market Size& Y-o-Y Growth Analysis 5.2.1. North America 6. North America Synthetic Biology Market Analysis and Forecast, by Product 6.1. Introduction and Definition 6.2. Key Findings 6.3. North America Synthetic Biology Market Value Share Analysis, by Product 6.4. Market Size (US$ Bn ) Forecast, by Product 6.5. Data Exfiltration Market Analysis, by Product 6.6. North America Synthetic Biology Market Attractiveness Analysis, by Product 7. North America Synthetic Biology Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. North America Synthetic Biology Market Value Share Analysis, by Application 7.3. Market Size (US$ Bn ) Forecast, by Application 7.4. North America Synthetic Biology Market Analysis, by Application 7.5. North America Synthetic Biology Market Attractiveness Analysis, by Application 8. North America Synthetic Biology Market Analysis and Forecast, by Technology 8.1. Introduction and Definition 8.2. North America Synthetic Biology Market Value Share Analysis, by Technology 8.3. Market Size (US$ Bn ) Forecast, by Technology 8.4. North America Synthetic Biology Market Analysis, by Technology 8.5. North America Synthetic Biology Market Attractiveness Analysis, by Technology 9. North America Synthetic Biology Market Analysis, by Country 9.1. North America Synthetic Biology Market Value Share Analysis, by Country 9.2. Market Size (US$ Bn ) Forecast, by Country 9.3. North America Synthetic Biology Market Attractiveness Analysis, by Country 10. North America Synthetic Biology Market Analysis 10.1. Key Findings 10.2. North America Synthetic Biology Market Overview 10.3. North America Synthetic Biology Market Value Share Analysis, by Product 10.4. North America Synthetic Biology Market Forecast, by Product 10.4.1. Enabling 10.4.2. Core 10.5. North America Synthetic Biology Market Value Share Analysis, by Application 10.6. North America Synthetic Biology Market Forecast, by Application 10.6.1. Chemicals 10.6.2. Healthcare 10.6.3. Agriculture 10.6.4. Others 10.7. North America Synthetic Biology Market Value Share Analysis, by Technology 10.8. North America Synthetic Biology Market Forecast, by Technology 10.8.1. Genome Engineering 10.8.2. Payers 10.8.3. Bioinformatics 10.8.4. Biological components and integrated systems 10.8.5. Others 10.9. North America Synthetic Biology Market Value Share Analysis, by Country 10.10. North America Synthetic Biology Market Forecast, by Country 10.10.1. U.S 10.10.2. Canada 10.10.3. Rest of North America 10.11. North America Synthetic Biology Market Analysis, by Country/ Sub-Country 10.12. U.S Healthcare Mobility Solutions Market Forecast, by Product 10.12.1. Enabling 10.12.2. Core 10.13. U.S Healthcare Mobility Solutions Market Forecast, by Application 10.13.1. Chemicals 10.13.2. Healthcare 10.13.3. Agriculture 10.13.4. Others 10.14. U.S Healthcare Mobility Solutions market Forecast, by Technology 10.14.1. Genome Engineering 10.14.2. DNA Sequencing 10.14.3. Bioinformatics 10.14.4. Biological components and integrated systems 10.14.5. Others 10.15. Canada Healthcare Mobility Solutions Market Forecast, by Product 10.15.1. Enabling 10.15.2. Core 10.16. Canada Healthcare Mobility Solutions Market Forecast, by Application 10.16.1. Chemicals 10.16.2. Healthcare 10.16.3. Agriculture 10.16.4. Others 10.17. Canada Healthcare Mobility Solutions Market Forecast, by Technology 10.17.1. Genome Engineering 10.17.2. DNA Sequencing 10.17.3. Bioinformatics 10.17.4. Biological components and integrated systems 10.17.5. Others 10.18. Rest of North America Synthetic Biology Market Forecast, by Product 10.18.1. Enabling 10.18.2. Core 10.19. Rest of North America Synthetic Biology Market Forecast, by Application 10.19.1. Chemicals 10.19.2. Healthcare 10.19.3. Agriculture 10.19.4. Others 10.20. Rest of North America Synthetic Biology Market Forecast, by Technology 10.20.1. Genome Engineering 10.20.2. DNA Sequencing 10.20.3. Bioinformatics 10.20.4. Biological components and integrated systems 10.20.5. Others 10.21. North America Synthetic Biology Market Attractiveness Analysis 10.21.1. By Product 10.21.2. By Application 10.21.3. By Technology 10.22. PEST Analysis 11. Company Profiles 11.1. Market Share Analysis, by Company 11.2. Competition Matrix 11.3. Company Profiles: Key Players 11.3.1. Thermo Fisher Scientific Inc 11.3.2. Company Overview 11.3.3. Financial Overview 11.3.4. Business Strategy 11.3.5. Recent Developments 11.3.6. Development Footprint 11.3.7. Integrated DNA Technologies, Inc. 11.3.8. Synthetic Genomics Inc. 11.3.9. Genscript Corporation 11.3.10. Amyris 11.3.11. Intrexon 11.3.12. Dupont 11.3.13. Agilent Technologies 11.3.14. Twist Bioscience 11.3.15. Origene Technologies, Inc. 12. Primary Key Insights

Inquiry Before Buying

Request Sample

About This Report

Report ID 1629
Published Date Feb 2018
Contact Us
Call Now